Vanguard Group Inc Care Dx, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,300,016 shares of CDNA stock, worth $66.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,300,016

Previous 4,119,682 4.38%

Holding current value

$66.8 Million

Previous $49.4 Million 7.89%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$7.96 - $12.37 $1.44 Million - $2.23 Million	180,334 Added 4.38%	4,300,016 $45.5 Million
Q4 2023 Feb 14, 2024	SELL	$4.9 - $12.86 $92,654 - $243,169	-18,909 Reduced 0.46%	4,119,682 $49.4 Million
Q3 2023 Nov 14, 2023	BUY	$7.0 - $11.26 $354,669 - $570,510	50,667 Added 1.24%	4,138,591 $29 Million
Q2 2023 Aug 14, 2023	SELL	$7.61 - $9.46 $8.26 Million - $10.3 Million	-1,084,859 Reduced 20.97%	4,087,924 $34.7 Million
Q1 2023 May 15, 2023	SELL	$8.83 - $17.61 $861,931 - $1.72 Million	-97,614 Reduced 1.85%	5,172,783 $47.3 Million

Q4 2022 Feb 10, 2023	BUY	$10.88 - $20.05 $2.23 Million - $4.11 Million	204,908 Added 4.05%	5,270,397 $60.1 Million
Q3 2022 Nov 14, 2022	BUY	$16.06 - $26.39 $1.29 Million - $2.12 Million	80,292 Added 1.61%	5,065,489 $86.2 Million
Q2 2022 Aug 12, 2022	BUY	$20.49 - $39.72 $6.98 Million - $13.5 Million	340,830 Added 7.34%	4,985,197 $107 Million
Q1 2022 May 13, 2022	SELL	$28.19 - $46.6 $17.6 Million - $29.1 Million	-625,473 Reduced 11.87%	4,644,367 $172 Million
Q4 2021 Feb 14, 2022	SELL	$41.2 - $73.6 $516,977 - $923,532	-12,548 Reduced 0.24%	5,269,840 $240 Million
Q3 2021 Nov 12, 2021	BUY	$59.15 - $91.99 $2.73 Million - $4.25 Million	46,150 Added 0.88%	5,282,388 $335 Million
Q2 2021 Aug 13, 2021	BUY	$63.02 - $95.11 $330 Million - $498 Million	5,236,238 New	5,236,238 $479 Million

Others Institutions Holding CDNA

# of Institutions

150

Shares Held

55.1M

Call Options Held

85.8K

Put Options Held

48.8K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $830M
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Care Dx, Inc. Transaction History